SoylentNews

quietus [soylentnews.org] writes:

German company CureVac has received a rather strange offer from the current White House.

On March 3, CureVac's CEO was invited [curevac.com] to the White House, for a meeting with President Trump, Vice Pence and several members of the Coronavirus Task Force. Asked for when a vaccin could be ready, he estimated that a potential candidate could be ready within a few months [reuters.com]. Apparently, that triggered the members of the meeting so much, that they've now offered to buy the company, at whatever price.

One condition though: production would be exclusively [reuters.com] for the United States.

The move is not exactly one to gain popularity, and follows on the heels of the President's worrying statement [whitehouse.gov] that "a large number of new clusters in the United States were seeded by travelers from Europe [nextstrain.org]".

Original Submission